Almac Diagnostics, EORTC Collaborate for Tumor Profiling

Article

Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.

Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples from their clinical trial data and that of pan-European Cancer network, SPECTA.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.